PMV Pharmaceuticals (PMVP) on Wednesday filed a registration statement for the potential sale of up to $200 million of its securities from time to time.

The filing covers common stock, preferred stock, debt securities, warrants, subscription rights, purchase contracts and units.

The company said it will disclose in the applicable prospectus supplement its intended use for the net proceeds.

Price: 1.59, Change: +0.03, Percent Change: +1.92